Enterprise Innovation

  • Cramer on AI in tech companies

    Jim Cramer says that Intel CEO's buy of a AI startup shows that the executive is thinking of the future and not the past.

  • Rare disease innovation: Amicus CEO

    John Crowley, Amicus Therapeutics CEO, discusses the development of "orphan drugs" for patients with rare diseases. What I know personally and professionally is if we make great medicines, we'll not only change people lives, we'll build great businesses, says Crowley.

  • Apple's next big thing

    Walter Mossberg, Recode Editor-at-Large, discusses Apple's upcoming launch event including what new features he's expecting.

  • Inside Tim Cook's Apple

    Rick Tetzeli, Fast Company Editor at Large, discusses a post-Steve Jobs Apple and how CEO Tim Cook is handling the technology giant.

  • Apple iPhone

    Walter Isaacson, President and CEO of The Aspen Institute & CNBC Contributor, discusses how Apple's business is faring as well as rumored features of the iPhone 7.

  • Hacking brains for peak performance

    CNBC's Josh Lipton reports on "biohacking" in Silicon Valley where people are trying to improve their lives through new supplements.

  • Singapore is changing the measuring sticks for success as it places greater emphasis on innovation.

  • Startup trends in Silicon Valley

    Dave McClure, 500 Startups Founding Partner, speaks with CNBC's Josh Lipton about the accelerator's demo day and what kinds of businesses we should expect to see more of out of Silicon Valley.

  • Express to the moon?

    Naveen Jain, Moon Express, discusses the private venture to launch an unmanned mission to the moon, eventually leading to commercial lunar tourism and colonization.

  • Time to buy FANG stocks?

    Cathie Wood, ARK Investment Management CEO & CIO, looks at what's working in the market and gives her best plays for the tech space.

  • Future of electronic medicine

    Dr. Moncef Slaoui, GSK Chairman of vaccines, speaks with CNBC's Meg Tirrell about bioelectronic medicine and the new joint effort between GSK and Alphabet.

  • Oppo Outlook

    Michael Tran of Oppo, now the leading smartphone brand in China, explains the firm's strategy in emerging markets and upcoming product launches.

  • A nurse holds a newborn baby at the labor ward of Singapore's Kandang Kerbau Hospital (KKH).

    Singapore's policymakers have long battled the country's low birth rate, but will little success so far.

  • Is lithium the new gas?

    Lithium may be "the new gasoline" and the key to the electric car revolution. CNBC's Phil LeBeau reports details on the great lithium race.

  • Verizon Yahoo

    Yahoo and AOL are declining assets which won't help Verizon build up its core strength in connectivity, says Global Equities Research's Trip Chowdhry.

  • Executive Edge: Facebook takes flight

    The "Squawk Box" news team discusses some of the morning's most provocative headlines, including Facebook's test flight of its drone, and Florida officials testing mosquitos near Miami for the Zika virus.

  • DOJ Antitrust Chief on health care mergers

    Bill Baer, Justice Department Antitrust Chief, announces two separate lawsuits against health insurance mergers.

  • Qualcomm CEO on future of smartphones

    Qualcomm CEO Steve Mollenkopf discusses his company's earnings beat, his positive view of the partnership between SoftBank and ARM Holdings, and the outlook for smartphone innovation.

  • Innovating ag & boosting farmers' harvests

    Ag-tech company Indigo announced it raised $100 million in new funding. David Perry, Indigo CEO, discusses tackling agriculture problems and his company's efforts in adding microbes back to plants to create healthier plants.

  • Musk's master plan

    CNBC's Phil LeBeau reports the latest information on Elon Musk's master plan for the future of Tesla.